Vivoryon Therapeutics’ Strategic Regional Licensing Partnership with Simcere Pharmaceutical Group Ltd.

Freshfields Bruckhaus Deringer advised Vivoryon Therapeutics N.V. Vivoryon Therapeutics N.V., a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines, signed a strategic regional licensing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here